Funding Crisis Hits Belfast Haematology Centre Plans
A highly anticipated project for constructing a new haematology centre in Belfast has encountered a major setback as the Department of Health (DoH) has withdrawn £1.5 million in funding. This development has left the Belfast Trust grappling with trying to reorganize resources and has drawn sharp criticism for jeopardizing cancer patient care.
During a Stormont health committee meeting, the Belfast Trust revealed that the DoH decision to retract the funding came after concerns regarding financial estimates and proposed relocation plans were raised. With the project now delayed by a year, the originally planned opening in March 2031 faces uncertainty.
Belfast Trust Chief Executive, Jennifer Welsh, emphasized the potential risk to the project due to these financial concerns. “Relocation of approximately 80 staff from Belfast City Hospital continues to pose a significant challenge,” she stated. Efforts are underway to find alternative means to finance the staff relocation, which has been marked as a critical part of the project’s advancement.
Community Concerns and Political Voices
Political figures and health experts are vocally expressing concerns. Democratic Unionist Party (DUP) member Diane Dodds articulated public disquiet regarding the current conditions faced by haemotology patients and stressed the urgent need for project resumption to protect vulnerable patients. The situation has been described as placing “very vulnerable” patients, particularly those with compromised immune systems, at risk due to lack of necessary facilities and isolation areas.
Nuala McAllister of the Alliance Party condemned the funding withdrawal as “disgraceful,” highlighting the importance of prioritizing funds for sectors serving highly vulnerable patients. She noted the heavy impact on those undergoing intense cancer treatments in Northern Ireland.
As the Belfast Trust looks into escalating the matter to the DoH’s permanent secretary, there is a widespread call for swift resolution to avoid prolonged risk to patient welfare. The DoH has yet to respond publicly to the concerns, and with the project hanging in limbo, it remains a contentious issue demanding immediate attention.
Photo by Igor Sporynin on Unsplash
